Research & Education

Lung cancer mortality rates linked to primary care provider density

Study shows mortality surprisingly not linked to thoracic oncology services

DENVER – Lung cancer remains the leading cause of cancer-related deaths and is tied as the third leading cause of death overall in industrialized c

Researchers provide rationale for use of targeted immunotherapy in sarcomatoid lung carcinomas

Find higher levels of programmed death ligand-1 in rare disease

DENVER – Sarcomatoid carcinomas of the lung include rare subtypes of poorly differentiated non–small-cell lung carcinomas of high grade and aggress

Digital chest tomosynthesis possible lung cancer screening tool

Detection rate comparable to CT screening at a lower cost

DENVER – Most lung cancers are detected when patients become symptomatic and have latestage disease.

PET-CT improves care of limited-stage small-cell lung cancer patients

Researchers find improved overall survival for LS-SCLC patients

DENVER – Each year, 13 percent of all newly diagnosed lung cancer patients are diagnosed with small-cell lung cancer (SCLC).

Immunohistochemistry effectively detects ALK rearrangement

Could be reliable and cost-effective diagnostic approach in lung cancer

DENVER – ALK rearrangement has been demonstrated to be a potent oncogenic driver and a promising therapeutic target in non-small cell lung cancer (

Study supports continued research on specific treatment for women with lung cancer who are never-smokers

This lung cancer associated with EGFR mutation and ER expression

DENVER – The incidence of lung cancer in women affects an estimated 516,000 women worldwide, of which 100,000 are in the United States and 70,000 i